• 1
    Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807817.
  • 2
    Rotman S, Collins AB, Colvin RB. C4d deposition in allografts: current concepts and interpretation. Transplant Rev 2005; 19: 6577.
  • 3
    Schmeding M, Dankof A, Krenn V et al. C4d in acute rejection after liver transplantation—a valuable tool in differential diagnosis to hepatitis-C recurrence. Am J Transplant 2006; 6: 523530.
  • 4
    Krukemeyer MG, Moeller J, Morawietz L et al. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004; 78: 6570.
  • 5
    Dankof A, Schmeding M, Morawietz L et al. Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. Virchows Arch 2005; 447: 8793.
  • 6
    Moeller J, Krukemeyer MG, Morawietz L et al. Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected accumulation of effector B cells and plasma cells. Virchows Arch 2005; 446: 325332.
  • 7
    Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005; 19: 110114.
  • 8
    Petrovic LM, Villamil FG, Vierling JM, Makowka L, Geller SA. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg 1997; 3: 398406.
  • 9
    Regev A, Molina E, Moura R et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 2004; 10: 12331239.
  • 10
    Verslype C, Nevens F, Sinelli N et al. Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection. J Hepatol 2003; 38: 208244.